925004-43-9 Usage
Uses
Used in Pharmaceutical Synthesis:
Meldrum's acid is used as a reagent in the synthesis of pharmaceuticals for its ability to react with various nucleophiles. This property allows for the creation of a wide range of pharmaceutical compounds, contributing to the development of new medications and therapies.
Used in Agrochemical Production:
In the agrochemical industry, Meldrum's acid is utilized as a reagent in the synthesis of various agrochemicals. Its versatility in reacting with nucleophiles aids in the development of compounds used in agriculture to protect crops and enhance yields.
Used in Specialty Chemicals Synthesis:
Meldrum's acid is employed as a reagent in the synthesis of specialty chemicals, where its ability to form various organic compounds is leveraged to create unique products for specific applications.
Used in Material Development:
Meldrum's acid has been studied for its potential application in the development of new materials, showcasing its potential to contribute to the advancement of material sciences.
Used in Heterocyclic Compounds Synthesis:
As a precursor, Meldrum's acid is used in the synthesis of various heterocyclic compounds, which are important in the fields of pharmaceuticals, agrochemicals, and other chemical industries due to their diverse range of applications.
Check Digit Verification of cas no
The CAS Registry Mumber 925004-43-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,5,0,0 and 4 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 925004-43:
(8*9)+(7*2)+(6*5)+(5*0)+(4*0)+(3*4)+(2*4)+(1*3)=139
139 % 10 = 9
So 925004-43-9 is a valid CAS Registry Number.
925004-43-9Relevant academic research and scientific papers
SPIROCHROMANON DERIVATIVES
-
Page/Page column 127, (2008/12/07)
The invention relates to a compound of a general formula (I): wherein Ar1 represents a group formed from an aromatic ring selected from a group consisting of benzene, pyrazole, isoxazole, pyridine, indole, 1H-indazole, 1H-furo[2,3-c]pyrazole, 1H-thieno[2,3-c]pyrazole, benzimidazole, 1,2-benzisoxazole, imidazo[1,2-a]pyridine, imidazo[1,5-a]pyridine and 1H-pyrazolo[3,4-b]pyridine, having Ar2, and optionally having one or two or more substituents selected from R3; R1 and R2 each independently represent a hydrogen atom, a halogen atom, a cyano group, a C2-C6 alkenyl group, a C1-C6 alkoxy group, a C2-C7 alkanoyl group, a C2-C7 alkoxycarbonyl group, an aralkyloxycarbonyl group, a carbamoyl-C1-C6 alkoxy group, a carboxy-C2-C6 alkenyl group, or a group of -Q1-N(Ra)-Q2-Rb; or a C1-C6 alkyl group optionally having a substituent; or an aryl or heterocyclic group optionally having a substituent; or a C1-C6 alkyl group or a C2-C6 alkenyl group having the aryl or heterocyclic group; T and U each independently represent a nitrogen atom or a methine group; and V represents an oxygen atom or a sulfur atom. The compound of the invention is useful as therapeutical agents for various ACC-related diseases.
